Experienced in Apolipoprotein C2 Deficiency

Maria C. Izar

Department Of Otorhinolaryngology Head And Neck Surgery, 
Sao Paulo, SP, BR 
Experienced in Apolipoprotein C2 Deficiency
Department Of Otorhinolaryngology Head And Neck Surgery, 
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Maria Izar practices in Sao Paulo, Brazil. Ms. Izar is rated as an Experienced expert by MediFind in the treatment of Apolipoprotein C2 Deficiency. Her top areas of expertise are High Cholesterol, Atherosclerosis, Familial Hypercholesterolemia, and Familial Lipoprotein Lipase Deficiency.

Her clinical research consists of co-authoring 56 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Apolipoprotein C2 Deficiency.

Gender
Female

Locations

Department Of Otorhinolaryngology Head And Neck Surgery, Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-16)
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-16)
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Drug: Inclisiran
Study Phase: Phase 3

56 Total Publications

A multi-society Delphi consensus statement on the diagnosis of familial chylomicronemia syndrome.
A multi-society Delphi consensus statement on the diagnosis of familial chylomicronemia syndrome.
Journal: Archives of endocrinology and metabolism
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Izar's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile